Stocks and Investing Stocks and Investing
Fri, August 28, 2020
Thu, August 27, 2020

Larry Biegelsen Maintained (ABT) at Buy with Increased Target to $115 on, Aug 27th, 2020


Published on 2024-10-27 12:42:47 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $107 to $115 on, Aug 27th, 2020.

Larry has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 4 analyists that currently disagree with Larry


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $109 on, Friday, July 17th, 2020

Contributing Sources